Result card
|
Authors: Pseudo218 Pseudo218, Pseudo73 Pseudo73
Internal reviewers: Paolo Giorgi Rossi, Lotte Groth Jensen
In many organised screening programmes the target population (those who are invited) is around 65-80 years and males. In some screening programmes additional risk factors must be present to be included to screening.
Programmes | |
NHS England: “NHS Abdominal Aortic Aneurysm (AAA) Screening Programme” |
{13} |
Trials | |
Chichester trial {14} |
Women aged 65-80 years; n=9342 |
Mass study {15} |
Men aged 65-80; n=6040 |
Denmark: Viborg Trial ({16}) |
Men aged 64-73 years; n=12,639 |
Western Australian Study {17} |
Men aged 65-83 years; n=41,000 |
Running trials | |
Denmark: NCT00662480 |
Ages eligible for study: 65 years to 74 years Genders eligible for study: male Accepts healthy volunteers: no Other inclusion criteria: living in the central region of Denmark |
Survey results |
|
{13} UKNational Screening Committee. NHS Abdominal Aortic Aneurysm (AAA) Screening Programme - Information for Health Professionals. 2010 {cited 2011-12-21; Available from: http://aaa.screening.nhs.uk/getdata.php?id=219
{14} Scott RA, Bridgewater SG, Ashton HA. Randomized clinical trial of screening for abdominal aortic aneurysm in women. The British journal of surgery. 2002 Mar;89(3):283-5.
{15} Ashton HA, Gao L, Kim LG, Druce PS, Thompson SG, Scott RA. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. The British journal of surgery. 2007 Jun;94(6):696-701.
{16} Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ (Clinical research ed. 2005 Apr 2;330(7494):750.
{17} Norman PE, Jamrozik K, Lawrence-Brown MM,LeMT, Spencer CA, Tuohy RJ, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ (Clinical research ed. 2004 Nov 27;329(7477):1259.